Health Care & Life Sciences » Biotechnology | Iris Biotechnologies Inc.

Iris Biotechnologies Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Cost of Goods Sold (COGS) incl. D&A
16.00
14.00
4.80
2.80
6.10
Gross Income
16.00
14.00
4.80
2.80
6.10
SG&A Expense
633.60
570.30
476.40
1,187.50
1,052.00
EBIT
649.60
584.30
481.20
1,190.30
1,058.10
Unusual Expense
12.80
-
-
-
112.90
Non Operating Income/Expense
209.70
-
-
-
-
Interest Expense
20.50
1.60
4.40
1.70
2.10
Pretax Income
473.20
586.00
485.50
1,192.00
1,173.10
Consolidated Net Income
473.20
586.00
485.50
1,192.00
1,173.10
Net Income
473.20
586.00
485.50
1,192.00
1,173.10
Net Income After Extraordinaries
473.20
586.00
485.50
1,192.00
1,173.10
Net Income Available to Common
473.20
586.00
485.50
1,192.00
1,173.10
EPS (Basic)
0.04
0.05
0.04
0.08
0.07
Basic Shares Outstanding
12,168.80
12,801.00
13,250.20
14,764.20
15,739.40
EPS (Diluted)
0.04
0.05
0.04
0.08
0.07
Diluted Shares Outstanding
12,168.80
12,801.00
13,250.20
14,764.20
15,739.40
EBITDA
633.60
570.30
476.40
1,187.50
1,052.00

About Iris Biotechnologies

View Profile
Address
5201 Great America Parkway
Santa Clara California 95054
United States
Employees -
Website http://www.irisbiotech.com
Updated 07/08/2019
Iris Biotechnologies, Inc. is a life sciences company focused on health care. It offers the best approach to the treatment of cancer and other diseases through actionable integration of molecular profiling in the clinical decision-making process. The Iris Nano-Biochip product pipeline include CancerChip, PrenatalChip, Integrated Blood Test, IVF applications, NeuroChip, MetabolicChip, CardioChip, and Chips for veterinary, agricultural, environmental, and other applications.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.